EH66ICD-11 MMS 2026-01
Fixed drug eruption
Description
The term fixed drug eruption describes the development of one or more annular or oval inflamed erythematous patches on the skin as a result of systemic exposure to a drug. The patches may develop into bullae. The inflamed patches normally resolve with post-inflammatory hyperpigmentation but typically recur at the same site(s), often with progressively more involved sites, following each reexposure to the drug. In extreme cases (generalised bullous fixed drug eruption) the clinical picture may mimic toxic epidermal necrolysis. A large number of drugs have been implicated as triggers.
Index terms
- Fixed drug eruption
- Limited fixed drug eruption
- Generalised bullous fixed drug eruption
Sibling codes
EH60– Exanthematic drug eruptionEH61– Drug-induced urticaria, angioedema or anaphylaxisEH62– Lichenoid drug eruptionEH63– Stevens-Johnson syndrome or toxic epidermal necrolysis due to drugEH64– Drug-induced erythrodermaEH65– DRESS syndromeEH67– Acne or acneiform reactions attributable to drugsEH6Y– Drug eruption of other specified typeEH6Z– Drug eruption of unspecified type
Foundation entity
Allowed postcoordination axes
Part of: 14: Diseases of the skin